Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 January 2007, Vol. 109, No. 2, pp. 552-559.
Prepublished online as a Blood First Edition Paper on September 21, 2006; DOI 10.1182/blood-2005-10-026294.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Methods, Figures, and Videos
Right arrow All Versions of this Article:
blood-2005-10-026294v1
109/2/552    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Antl, M.
Right arrow Articles by Schlossmann, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Antl, M.
Right arrow Articles by Schlossmann, J.
Related Collections
Right arrow Cell Adhesion and Motility
Right arrow Signal Transduction
Right arrow Hemostasis, Thrombosis, and Vascular Biology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY

IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation

Melanie Antl1, Marie-Luise von Brühl2, Christina Eiglsperger1, Matthias Werner1, Ildiko Konrad2, Thomas Kocher3, Matthias Wilm4, Franz Hofmann1, Steffen Massberg2,5,6, and Jens Schlossmann1,

1 Institut für Pharmakologie und Toxikologie der Technischen Universität München, Munich, Germany; 2 Deutsches Herzzentrum und 1. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany; 3 Biological and Medical Mass Spectrometry, Uppsala Biomedical Centre, Uppsala, Sweden; 4 Protein and Peptide Group, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany; 5 Institute for Biomedical Research (CBR), Harvard Medical School, Boston, MA; 6 Department of Pathology, Harvard Medical School, Boston, MA

Defective regulation of platelet activation/aggregation is a predominant cause for arterial thrombosis, the major complication of atherosclerosis triggering myocardial infarction and stroke. A central regulatory pathway conveying inhibition of platelet activation/aggregation is nitric oxide (NO)/cyclic GMP (cGMP) signaling by cGMP-dependent protein kinase I (cGKI). However, the regulatory cascade downstream of cGKI mediating platelet inhibition is still unclear. Here, we show that the inositol-1,4,5-trisphosphate receptor–associated cGMP kinase substrate (IRAG) is abundantly expressed in platelets and assembled in a macrocomplex together with cGKIß and the inositol-1,4,5-trisphosphate receptor type I (InsP3RI). cGKI phosphorylates IRAG at Ser664 and Ser677 in intact platelets. Targeted deletion of the IRAG-InsP3RI interaction in IRAG{Delta}12/{Delta}12 mutant mice leads to a loss of NO/cGMP-dependent inhibition of fibrinogen-receptor activation and platelet aggregation. Intracellular calcium transients were not affected by DEA/NO or cGMP in mutant platelets. Furthermore, intravital microscopy shows that NO fails to prevent arterial thrombosis of the injured carotid artery in IRAG{Delta}12/{Delta}12 mutants. These findings reveal that interaction between IRAG and InsP3RI has a central role in NO/cGMP-dependent inhibition of platelet aggregation and in vivo thrombosis.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Circ. Res.Home page
S. Weber, D. Bernhard, R. Lukowski, P. Weinmeister, R. Worner, J. W. Wegener, N. Valtcheva, S. Feil, J. Schlossmann, F. Hofmann, et al.
Rescue of cGMP Kinase I Knockout Mice by Smooth Muscle Specific Expression of Either Isozyme
Circ. Res., November 26, 2007; 101(11): 1096 - 1103.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. L. Bilodeau and H. E. Hamm
Regulation of Protease-Activated Receptor (PAR) 1 and PAR4 Signaling in Human Platelets by Compartmentalized Cyclic Nucleotide Actions
J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 778 - 788.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
I. Russo, P. Del Mese, G. Doronzo, A. De Salve, M. Secchi, M. Trovati, and G. Anfossi
Platelet Resistance to the Antiaggregatory Cyclic Nucleotides in Central Obesity Involves Reduced Phosphorylation of Vasodilator-Stimulated Phosphoprotein
Clin. Chem., June 1, 2007; 53(6): 1053 - 1060.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
C.-u. Choe and B. E. Ehrlich
The Inositol 1,4,5-Trisphosphate Receptor (IP3R) and Its Regulators: Sometimes Good and Sometimes Bad Teamwork
Sci. Signal., November 28, 2006; 2006(363): re15 - re15.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020